Transposons: Moving Forward from Preclinical Studies to Clinical Trials

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Human Gene Therapy

• Publication date

  2017-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1089/hum.2017.128PMID 28920716
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Enhanced CAR T-cell engineering using non-viral Sleeping Beauty transposition from minicircle vectors

  2017cited by this paper
• Long-Term Prevention of Congenital Thrombotic Thrombocytopenic Purpura in ADAMTS13 Knockout Mice by Sleeping Beauty Transposon-Mediated Gene Therapy

  2017cited by this paper
• Gene therapy for ADA‐SCID, the first marketing approval of an ex vivo gene therapy in Europe: paving the road for the next generation of advanced therapy medicinal products

  2017cited by this paper
• The Principles of Engineering Immune Cells to Treat Cancer.

  2017cited by this paper
• Sleeping Beauty transposition: from biology to applications

  2017cited by this paper
• Kidney-specific transposon-mediated gene transfer in vivo

  2017cited by this paper
• Mesothelin-targeting chimeric antigen receptor–modified T cells by piggyBac transposon system suppress the growth of bile duct carcinoma

  2017cited by this paper
• Reversal of Phenotypic Abnormalities by CRISPR/Cas9-Mediated Gene Correction in Huntington Disease Patient-Derived Induced Pluripotent Stem Cells

  2017cited by this paper
• In situ programming of leukaemia-specific T cells using synthetic DNA nanocarriers.

  2017cited by this paper
• Correction of Recessive Dystrophic Epidermolysis Bullosa by Transposon-Mediated Integration of COL7A1 in Transplantable Patient-Derived Primary Keratinocytes.

  2017cited by this paper
• Prolonged Expression of Secreted Enzymes in Dogs After Liver-Directed Delivery of Sleeping Beauty Transposons: Implications for Non-Viral Gene Therapy of Systemic Disease

  2017influential reference
• Transgene Expression in Dogs After Liver-Directed Hydrodynamic Delivery of Sleeping Beauty Transposons Using Balloon Catheters

  2017cited by this paper
• Engineering of PEDF-Expressing Primary Pigment Epithelial Cells by the SB Transposon System Delivered by pFAR4 Plasmids

  2017cited by this paper
• Sleeping Beauty Transposon Vectors in Liver-directed Gene Delivery of LDLR and VLDLR for Gene Therapy of Familial Hypercholesterolemia.

  2016cited by this paper
• Efficient, footprint-free human iPSC genome editing by consolidation of Cas9/CRISPR and piggyBac technologies

  2016cited by this paper
• Phase I trials using Sleeping Beauty to generate CD19-specific CAR T cells.

  2016cited by this paper
• Long-Term Retrospective Analysis of Gene Therapy with Alipogene Tiparvovec and Its Effect on Lipoprotein Lipase Deficiency-Induced Pancreatitis

  2016cited by this paper
• Transgenesis of Tol2-mediated seamlessly constructed BAC mammary gland expression vectors in Mus musculus.

  2016cited by this paper
• Restricting retrotransposons: a review

  2016cited by this paper
• Targeted delivery of nerve growth factor to the cholinergic basal forebrain of Alzheimer’s disease patients: application of a second-generation encapsulated cell biodelivery device

  2016cited by this paper
• Anti-proliferative effects of T cells expressing a ligand-based chimeric antigen receptor against CD116 on CD34+ cells of juvenile myelomonocytic leukemia

  2016cited by this paper
• The Functionality of Minimal PiggyBac Transposons in Mammalian Cells

  2016cited by this paper
• A High-Capacity Adenoviral Hybrid Vector System Utilizing the Hyperactive Sleeping Beauty Transposase SB100X for Enhanced Integration

  2016cited by this paper
• Stable, Nonviral Expression of Mutated Tumor Neoantigen-specific T-cell Receptors Using the Sleeping Beauty Transposon/Transposase System.

  2016cited by this paper
• Full-length Dysferlin Transfer by the Hyperactive Sleeping Beauty Transposase Restores Dysferlin-deficient Muscle

  2016cited by this paper
• Long-Term Expression of Von Willebrand Factor Via Piggybac -Mediated Gene Transfer

  2016cited by this paper
• Active recombinant Tol2 transposase for gene transfer and gene discovery applications

  2016cited by this paper
• Hepatic Overexpression of Hemopexin Inhibits Inflammation and Vascular Stasis in Murine Models of Sickle Cell Disease

  2016cited by this paper
• Ultrasound-targeted hepatic delivery of factor IX in hemophiliac mice

  2016cited by this paper
• Redirecting Specificity of T cells Using the Sleeping Beauty System to Express Chimeric Antigen Receptors by Mix-and-Matching of VL and VH Domains Targeting CD123+ Tumors

  2016cited by this paper
• Parameter Estimation of Fractional-Order Chaotic Systems by Using Quantum Parallel Particle Swarm Optimization Algorithm

  2015cited by this paper
• Mesoangioblast delivery of miniagrin ameliorates murine model of merosin-deficient congenital muscular dystrophy type 1A

  2015cited by this paper
• Antileukemic potency of CD19-specific T cells against chemoresistant pediatric acute lymphoblastic leukemia.

  2015cited by this paper
• Pax3-induced expansion enables the genetic correction of dystrophic satellite cells

  2015cited by this paper
• IGF1R- and ROR1-Specific CAR T Cells as a Potential Therapy for High Risk Sarcomas

  2015cited by this paper
• Derivation and Characterization of Bovine Induced Pluripotent Stem Cells by Transposon-Mediated Reprogramming

  2015cited by this paper
• Generation of Naïve Bovine Induced Pluripotent Stem Cells Using PiggyBac Transposition of Doxycycline-Inducible Transcription Factors

  2015cited by this paper
• Gene therapy returns to centre stage

  2015cited by this paper
• Non-viral gene therapy by liver-directed hydrodynamic delivery of Sleeping Beauty transposons to treat MPS in dogs

  2015cited by this paper
• Sleeping Beauty Transposition of Chimeric Antigen Receptors Targeting Receptor Tyrosine Kinase-Like Orphan Receptor-1 (ROR1) into Diverse Memory T-Cell Populations

  2015cited by this paper
• piggyBac transposons expressing full-length human dystrophin enable genetic correction of dystrophic mesoangioblasts

  2015cited by this paper
• Novel Gene Therapy Strategy for Hemophilia a By Hydrodynamic Gene Delivery Combined with Non-Viral Piggybac Transposon Vector in Canine Model

  2015cited by this paper
• Low-cost generation of Good Manufacturing Practice-grade CD19-specific chimeric antigen receptor-expressing T cells using piggyBac gene transfer and patient-derived materials.

  2015cited by this paper
• Stable Somatic Gene Expression in Mouse Lungs Following Electroporation-mediated Tol2 Transposon Delivery.

  2015cited by this paper
• Sustained high level transgene expression in mammalian cells mediated by the optimized piggyBac transposon system

  2015cited by this paper
• piggyBac Transposon

  2015cited by this paper
• Protective role of insulin-like growth factor-1 receptor in endothelial cells against unilateral ureteral obstruction-induced renal fibrosis.

  2015cited by this paper
• Hybrid nonviral/viral vector systems for improved piggyBac DNA transposon in vivo delivery.

  2015cited by this paper
• The Impact of Transposable Elements in Genome Evolution and Genetic Instability and Their Implications in Various Diseases

  2014cited by this paper
• Characterization of Constitutive Promoters for piggyBac Transposon-Mediated Stable Transgene Expression in Mesenchymal Stem Cells (MSCs)

  2014cited by this paper
• Anti-leukemic potency of piggyBac-mediated CD19-specific T cells against refractory Philadelphia chromosome-positive acute lymphoblastic leukemia.

  2014cited by this paper
• H-ferritin ferroxidase induces cytoprotective pathways and inhibits microvascular stasis in transgenic sickle mice

  2014cited by this paper
• Seamless gene correction of β-thalassemia mutations in patient-specific iPSCs using CRISPR/Cas9 and piggyBac

  2014cited by this paper
• Seamless correction of the sickle cell disease mutation of the HBB gene in human induced pluripotent stem cells using TALENs.

  2014cited by this paper
• A PiggyBac-mediated approach for muscle gene transfer or cell therapy.

  2014cited by this paper
• Mesenchymal Stem Cells Do Not Prevent Antibody Responses against Human α-L-Iduronidase when Used to Treat Mucopolysaccharidosis Type I

  2014cited by this paper
• Hyperactive PiggyBac Transposons for Sustained and Robust Liver-targeted Gene Therapy

  2014cited by this paper
• Genomic Analysis of Sleeping Beauty Transposon Integration in Human Somatic Cells

  2014cited by this paper
• Gene Therapy for Wiskott-Aldrich Syndrome—Long-Term Efficacy and Genotoxicity

  2014cited by this paper
• Hyperactive PiggyBac Transposons for Sustained and Robust Liver-targeted Gene Therapy.

  2014cited by this paper
• piggyBac-mediated phenotypic correction of factor VIII deficiency

  2014cited by this paper
• Non-viral reprogramming of fibroblasts into induced pluripotent stem cells by Sleeping Beauty and piggyBac transposons.

  2014cited by this paper
• The Tol2 transposon system mediates the genetic engineering of T-cells with CD19-specific chimeric antigen receptors for B-cell malignancies

  2014cited by this paper
• Delivery of Full-Length Factor VIII Using a piggyBac Transposon Vector to Correct a Mouse Model of Hemophilia A

  2014cited by this paper
• Non-viral vectors for gene-based therapy

  2014cited by this paper
• Corrigendum: Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs

  2014cited by this paper
• β-Globin Sleeping Beauty Transposon Reduces Red Blood Cell Sickling in a Patient-Derived CD34+-Based In Vitro Model

  2013cited by this paper
• Simple piggyBac transposon-based mammalian cell expression system for inducible protein production

  2013cited by this paper
• Efficient Sleeping Beauty DNA Transposition From DNA Minicircles

  2013cited by this paper
• Seamless genome editing in human pluripotent stem cells using custom endonuclease–based gene targeting and the piggyBac transposon

  2013cited by this paper
• Retrovirus-based mRNA transfer for transient cell manipulation.

  2013cited by this paper
• Integration Profile and Safety of an Adenovirus Hybrid-Vector Utilizing Hyperactive Sleeping Beauty Transposase for Somatic Integration

  2013cited by this paper
• Hybrid Adeno-Associated Viral Vectors Utilizing Transposase-Mediated Somatic Integration for Stable Transgene Expression in Human Cells

  2013influential reference
• A Novel Piggybac Transposon Inducible Expression System Identifies a Role for Akt Signalling in Primordial Germ Cell Migration

  2013cited by this paper
• Exogenous mRNA delivery and bioavailability in gene transfer mediated by piggyBac transposition

  2013cited by this paper
• Derivation and Characterization of Sleeping Beauty Transposon-Mediated Porcine Induced Pluripotent Stem Cells

  2013cited by this paper
• Synergetic Targeted Delivery of Sleeping‐Beauty Transposon System to Mesenchymal Stem Cells Using LPD Nanoparticles Modified with a Phage‐Displayed Targeting Peptide

  2013cited by this paper
• An ex vivo Gene Therapy Approach to Treat Muscular Dystrophy Using inducible Pluripotent Stem Cells

  2013cited by this paper
• Generation of induced pluripotent stem cells from human foetal fibroblasts using the Sleeping Beauty transposon gene delivery system.

  2013cited by this paper
• Efficient and Reproducible Myogenic Differentiation from Human iPS Cells: Prospects for Modeling Miyoshi Myopathy In Vitro

  2013cited by this paper
• Transposon‐mediated transgenesis, transgenic rescue, and tissue‐specific gene expression in rodents and rabbits

  2013cited by this paper
• Quantitative Analysis of α-L-Iduronidase Expression in Immunocompetent Mice Treated with the Sleeping Beauty Transposon System

  2013cited by this paper
• Endothelial indoleamine 2,3-dioxygenase protects against development of pulmonary hypertension.

  2013cited by this paper
• Loss of glutathione S‐transferase A4 accelerates obstruction‐induced tubule damage and renal fibrosis

  2012cited by this paper
• Sleeping Beauty Transposon System is a Reliable Gene Delivery Tool for Hereditary Tyrosinaemia Type 1 Disease Gene Therapy: Size of the Foreign Gene Decides the Timing of Stable Integration into the Host Chromosomes

  2012cited by this paper
• Chimeric piggyBac transposases for genomic targeting in human cells

  2012cited by this paper
• Hyperactive piggyBac Gene Transfer in Human Cells and In Vivo

  2012cited by this paper
• Genetically modified T cells targeting interleukin-11 receptor α-chain kill human osteosarcoma cells and induce the regression of established osteosarcoma lung metastases.

  2012cited by this paper
• Muscle biopsy evaluation in neuromuscular disorders.

  2012cited by this paper
• PiggyBac toolbox.

  2012cited by this paper
• Recent developments in transposon-mediated gene therapy

  2012cited by this paper
• miR-29 inhibits bleomycin-induced pulmonary fibrosis in mice.

  2012cited by this paper
• Sleeping Beauty transposon-based system for cellular reprogramming and targeted gene insertion in induced pluripotent stem cells

  2012cited by this paper
• Increased encapsulated cell biodelivery of nerve growth factor in the brain by transposon-mediated gene transfer

  2011cited by this paper
• Sleeping Beauty‐mediated correction of Fanconi anemia type C

  2011cited by this paper
• Transgene-free production of pluripotent stem cells using piggyBac transposons.

  2011cited by this paper
• Avoiding cytotoxicity of transposases by dose-controlled mRNA delivery

  2011cited by this paper
• Manipulating piggyBac transposon chromosomal integration site selection in human cells.

  2011cited by this paper
• State-of-the-art gene-based therapies: the road ahead

  2011cited by this paper
• Comparative genomic integration profiling of Sleeping Beauty transposons mobilized with high efficacy from integrase-defective lentiviral vectors in primary human cells.

  2011cited by this paper

• Activity of the mammalian DNA transposon piggyBat from Myotis lucifugus is restricted by its own transposon ends

  2025cites this paper
• Deconstructing gene therapy in hemophilia for the clinician.

  2025cites this paper
• Multiple Buster transposons from hAT superfamily displaying transposition activities in mammal cells

  2025cites this paper
• Transgene integration in mammalian cells: The tools, the challenges, and the future.

  2025cites this paper
• Current biological, chemical and physical gene delivery approaches for producing induced pluripotent stem cells (iPSCs).

  2025cites this paper
• Novel strategies to overcome tumor immunotherapy resistance using CAR NK cells

  2025cites this paper
• The deLIVERed promises of gene therapy: past, present and future of liver-directed gene therapy.

  2025cites this paper
• Integration of therapeutic cargo into the human genome with programmable type V-K CAST

  2025cites this paper
• In vivo vectorization and delivery systems for gene therapies and RNA-based therapeutics in oncology.

  2025cites this paper
• Challenges and Considerations of Preclinical Development for iPSC-Based Myogenic Cell Therapy

  2024cites this paper
• Advancements in the design and function of bispecific CAR-T cells targeting B Cell-Associated tumor antigens.

  2024cites this paper
• Non-viral approaches in CAR-NK cell engineering: connecting natural killer cell biology and gene delivery

  2024influential citation
• Progress and pitfalls of gene editing technology in CAR-T cell therapy: a state-of-the-art review

  2024cites this paper
• The paths toward non-viral CAR-T cell manufacturing: A comprehensive review of state-of-the-art methods.

  2024cites this paper
• Mobile genetic element-based gene editing and genome engineering: Recent advances and applications.

  2024cites this paper
• Tn5 DNA Transposase in Multi-Omics Research

  2023cites this paper
• Genetic Manipulation Approaches to Enhance the Clinical Application of NK Cell-Based Immunotherapy

  2023cites this paper
• A mammalian cell display platform based on scFab transposition.

  2023cites this paper
• Non-viral technologies can pave the way for CAR-NK cell therapy.

  2023cites this paper
• Construction and Applications of Mammalian Cell-Based DNA-Encoded Peptide/Protein Libraries.

  2023cites this paper
• Targeted DNA integration in human cells without double-strand breaks using CRISPR-associated transposases

  2023cites this paper
• Targeted DNA integration in human cells without double-strand breaks using CRISPR RNA-guided transposases

  2023cites this paper
• Transition from Animal-Based to Human Induced Pluripotent Stem Cells (iPSCs)-Based Models of Neurodevelopmental Disorders: Opportunities and Challenges

  2023cites this paper
• Technology digest: non-viral vectors.

  2022cites this paper
• Improved alpharetrovirus-based Gag.MS2 particles for efficient and transient delivery of CRISPR-Cas9 into target cells

  2022cites this paper
• Constitutive Heterochromatin in Eukaryotic Genomes: A Mine of Transposable Elements

  2022cites this paper
• Degron tagging of BleoR and other antibiotic-resistance genes selects for higher expression of linked transgenes and improved exosome engineering

  2022cites this paper
• Universal allogeneic CAR T cells engineered with Sleeping Beauty transposons and CRISPR-CAS9 for cancer immunotherapy

  2022cites this paper
• Gene-Based Natural Killer Cell Therapies for the Treatment of Pediatric Hematologic Malignancies.

  2022cites this paper
• Current Status and Perspectives of Dual-Targeting Chimeric Antigen Receptor T-Cell Therapy for the Treatment of Hematological Malignancies

  2022cites this paper
• Programmable RNA-Guided Large DNA Transgenesis by CRISPR/Cas9 and Site-Specific Integrase Bxb1

  2022cites this paper
• CAR NK cell therapy in hematologic malignancies and solid tumors; obstacles and strategies to overcome the challenges.

  2022cites this paper
• Functional Characterization of the N-Terminal Disordered Region of the piggyBac Transposase

  2022cites this paper
• Advances in Promoting the Efficacy of Chimeric Antigen Receptor T Cells in the Treatment of Hepatocellular Carcinoma

  2022cites this paper
• Horizontal Transfer and Evolutionary Profiles of Two Tc1/DD34E Transposons (ZB and SB) in Vertebrates

  2022cites this paper
• Choice of selectable marker affects recombinant protein expression in cells and exosomes

  2021cites this paper
• Applications of piggyBac Transposons for Genome Manipulation in Stem Cells

  2021cites this paper
• In Vitro and In Vivo Model Systems of Cholangiocarcinoma

  2021cites this paper
• Nonviral genome engineering of natural killer cells

  2021cites this paper
• Functional analysis of the catalytic triad of the hAT-family transposase TcBuster.

  2021cites this paper
• The Dynamism of Transposon Methylation for Plant Development and Stress Adaptation

  2021cites this paper
• Contemporary Transposon Tools: A Review and Guide through Mechanisms and Applications of Sleeping Beauty, piggyBac and Tol2 for Genome Engineering

  2021cites this paper
• Structural basis of seamless excision and specific targeting by piggyBac transposase

  2020cites this paper
• Editorial: Enabling Biomaterials for New Biomedical Technologies and Clinical Therapies

  2020cites this paper
• Transposon vector-mediated stable gene transfer for the accelerated establishment of recombinant mammalian cell pools allowing for high-yield production of biologics

  2020cites this paper
• Nanotechnology Promotes Genetic and Functional Modifications of Therapeutic T Cells Against Cancer

  2020cites this paper
• Gene Therapy Clinical Trials

  2020cites this paper
• Jump around: transposons in and out of the laboratory

  2020cites this paper
• Validation of miR-20a as a Tumor Suppressor Gene in Liver Carcinoma Using Hepatocyte-Specific Hyperactive piggyBac Transposons

  2020cites this paper
• Artificial T Cell Adaptor Molecule-Transduced TCR-T Cells Demonstrated Improved Proliferation Only When Transduced in a Higher Intensity

  2020cites this paper
• T-cell–engaging Therapy for Solid Tumors

  2020cites this paper
• Light control of RTK activity: from technology development to translational research

  2020cites this paper
• The Landscape of CAR-T Cell Clinical Trials against Solid Tumors—A Comprehensive Overview

  2020cites this paper
• Current status and hurdles for CAR-T cell immune therapy

  2019cites this paper
• Utilization of Chimeric Antigen Receptor (CAR) T Cell Therapy in Clinical Practice for Relapsed/Refractory Aggressive B cell non-Hodgkin Lymphoma: An Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy.

  2019cites this paper
• Genomic Analyses of SLAMF7 CAR-T Cells Manufactured by Sleeping Beauty Transposon Gene Transfer for Immunotherapy of Multiple Myeloma

  2019cites this paper
• At the Intersection of Biomaterials and Gene Therapy: Progress in Non-viral Delivery of Nucleic Acids

  2019cites this paper
• From synthetic biology to human therapy: engineered mammalian cells.

  2019cites this paper
• Gene editing enables T-cell engineering to redirect antigen specificity for potent tumor rejection

  2019cites this paper
• Evolution-guided evaluation of the inverted terminal repeats of the synthetic transposon Sleeping Beauty

  2019cites this paper
• An insight into non-integrative gene delivery approaches to generate transgene-free induced pluripotent stem cells.

  2019cites this paper
• A Modified Sleeping Beauty Transposon Vector System Integrates and Settles Genes in the Genome

  2019cites this paper
• PiggyBac transposon system with polymeric gene carrier transfected into human T cells.

  2019cites this paper
• Can Hsp Targeted Gene Therapy Be a New Hope for Gliomas?

  2019cites this paper
• Adenovirus vectors in hematopoietic stem cell genome editing

  2019cites this paper
• PiggyBac-engineered T cells expressing a glypican-3-specific chimeric antigen receptor show potent activities against hepatocellular carcinoma.

  2019cites this paper
• Industrializing Autologous Adoptive Immunotherapies: Manufacturing Advances and Challenges

  2018cites this paper
• Non-viral therapeutic cell engineering with the Sleeping Beauty transposon system.

  2018cites this paper
• The Pharmacology of T Cell Therapies

  2018cites this paper
• Preclinical Efficacy and Safety of CD19CAR Cytokine-Induced Killer Cells Transfected with Sleeping Beauty Transposon for the Treatment of Acute Lymphoblastic Leukemia

  2018cites this paper